- €531.71m
- €351.61m
- €876.69m
- 79
- 72
- 27
- 64
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 742 | 825 | 984 | 1,039 | 877 |
Cost of Revenue | |||||
Gross Profit | 218 | 212 | 253 | 242 | 188 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 706 | 783 | 928 | 992 | 910 |
Operating Profit | 35.2 | 41.9 | 55.4 | 46.6 | -33.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 36.2 | 41.6 | 55 | 45.9 | -32.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.8 | 28.6 | 38 | 31.8 | -28.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 29.8 | 28.6 | 38 | 31.8 | -28.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.8 | 28.6 | 38 | 31.8 | -28.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.666 | 0.64 | 0.85 | 0.711 | -0.63 |
Dividends per Share |